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Calystegines are Potential Urine Biomarkers for Dietary
Exposure to Potato Products
Manfred Beckmann, Amanda J. Lloyd, Thomas Wilson, Duarte P. M. Torres,
Ana C. L. Goios, Naomi D. Willis, Laura Lyons, Helen Phillips, John C. Mathers,
Robert J. Nash, Hazel Sharp, and John Draper*
Scope: Metabolites derived from specific foods present in urine samples can
provide objective biomarkers of food intake (BFIs). This study investigated the
possibility that calystegines (a class of iminosugars) may provide BIFs for
potato (Solanum tuberosum L.) product exposure.
Methods and results: Calystegine content is examined in published data
covering a wide range of potato cultivars. Rapid methods are developed for
the quantification of calystegines in cooked potato products and human urine
using triple quadrupole mass spectrometry. The potential of calystegines as
BFIs for potato consumption is assessed in a controlled food intervention
study in the United Kingdom and validated in an epidemiological study in
Portugal. Calystegine concentrations are reproducibly above the quantification
limit in first morning void urines the day after potato consumption, showing a
good dose-response relationship, particularly for calystegine A3. The design of
the controlled intervention mimicks exposure to a typical UK diet and showed
that neither differences in preparation/cooking method or influence of other
foods in the diet has significant impact on biomarker performance.
Calystegine biomarkers also perform well in the independent validation study.
Conclusion: It is concluded that calystegines have many of the characteristics
needed to be considered as specific BFIs for potato product intake.
1. Introduction
After the major cereals rice, wheat and corn, potato tubers
(Solanum tuberosum L.) are the most widely consumed starchy
food internationally.[1] In addition, potato contributes significant
amounts of vitamins (including vitamin C), minerals (including
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potassium), amino acids, and dietary
fiber to many human diets. Although
higher intakes of potatoes have been
linked to increased rates of obesity, dia-
betes, and cardiovascular disease in some
studies,[2] it is probable that any such
associations were due to the fat added
during cooking. Despite being a staple
component of the diet in many countries
globally, the impact of potato consump-
tion on human health is relatively poorly
understood.[2] Potato tubers contain a
range of potentially toxic substances in-
cluding glycoalkaloids and the starch in
potatoes is largely indigestible without
processing and cooking.[3] In addition
to domestic processing including peel-
ing, blanching, baking, and frying of raw
tubers to produce chips (French fries),
roasted potatoes, jacket potatoes, and
boiled/mashed potatoes, a wide range
of processed potato products are avail-
able commercially. Many of these pro-
cessed foods are based on reconstituted
potato and show considerable composi-
tional differences from the raw tuber.
Additionally, potato is a common component of ready-made com-
plexmeals. This diversity in uses of potatomeans that consumers
often have difficulty quantifying accurately the amount of potato
in their diet, making it challenging to link health outcomes to
potato exposure.
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Dietary exposure can be estimated using self-reported mea-
sures such as food frequency questionnaires (FFQs), 24-h recall
and diet diaries/records. However these methods have well un-
derstood limitations as a result of substantial misreporting and
bias,[4] which is often exacerbated in those who are overweight
or obese.[5,6] It has been demonstrated recently that metabolites
derived from specific foods or food groups present in urine sam-
ples can provide biomarkers of dietary exposure.[7–11] Including
measurement of biomarkers of food intake (BFIs)[12,13] could
overcome some of the limitations of traditional dietary assess-
ment methodologies by providing additional objective estimates
of food exposure.[14]
A recent literature review exploring possible biomarkers of
potato tuber intake[15] identified derivatives of polyphenol sec-
ondary metabolites (including chlorogenic acids) in urine fol-
lowing exposure to potato tuber products, but none could be
considered specific to potato consumption. Similarly, a range of
compounds resulting from the heating of potato products (in-
cluding alkyl pyrazines, acrylamide and acrolein) were found in
urine, but again a specific association with general potato con-
sumption was considered unlikely. Several studies suggested that
the well-known potato glycoalkaloids: alpha-solanine and alpha-
chaconine, may providemore specific biomarkers of potato expo-
sure. However, potato glycoalkaloid content was generally mea-
sured only in plasma or serum samples,[16–18] with no reports of
their presence in urine. Although certainly specific to potato, the
use of these compounds as general biomarkers of potato expo-
sure may prove problematic as the glycoalkaloid content is con-
fined largely to the skin and because concentrations increase
dramatically after tuber “greening” caused by post-harvest ex-
posure to light and wounding.[19,20] This characteristic distribu-
tion and response to environment means that consumption of
potato-based foods that include the outer layers of the tuber will
result in exposure to much higher levels of glycoalkaloids than
that achieved after eating products derived from peeled potatoes.
Furthermore, since higher concentrations of these toxins in food
products is considered undesirable cultivar selection; agronomic
practices, and storage and processing protocols are designed to
lower the concentration of glycoalkaloids in potato-based food
products.[19]
Calystegines are a family of nortropane alkaloids (a class of
iminosugars) found largely in solanaceous plants,[20–23] where
common forms include calystegines A3 and B2 (Data S1, Sup-
porting Information). Calystegines were first detected in potatoes
in the 1990s and, although not toxic to humans, may have po-
tential to reduce glucose absorption resulting from inhibition of
glycosidase enzymes.[24–26] Potato calystegines, in particular, may
have benefits in stabilizing glucocerebrosidase which is deficient
in Parkinson’s and Gaucher’s diseases.[27] Analytical methods for
the determination of calystegines in plant-derived samples have
been reviewed recently.[23] Because of their highly polar nature,
earlier analytical approaches included a purification step using
ion exchange columns followed by concentration by either freeze
drying or rotary evaporation prior to derivatization and analysis
by gas chromatography mass spectrometry (GC-MS). More
recently, measurement of calystegines in plant extracts has been
simplified by the use of liquid chromatography coupled to mass
spectrometry (LC-MS) which avoids the need for purification
and derivatization steps.[20,28] Concentrations of calystegines vary
among potato cultivars and, although lacking extensive study,
calystegines appear to be distributed relatively evenly throughout
potato tubers but with slightly higher concentrations in the
peel.[21,22,29,30] Unlike glycoalklaloids, calystegine metabolism
is generally not influenced by postharvest exposure of potato
tubers to wounding or light.[20]
To date, there are no reports of human food interventions that
have studied the absorption, metabolism, and excretion of potato
calystegines and so the utility of this class of compounds as po-
tential urinary BFIs for potato tuber exposure has yet to be in-
vestigated. In the present study, we surveyed calystegines con-
centrations in a range of potato genotypes reported in previous
studies. Rapid and sensitive micro-scale LC-MS/MSmethods for
the analysis of calystegines in cooked potato products and human
urine have been developed and used to examine their potential
as biomarkers of potato tuber consumption in both a controlled
food intervention and an epidemiological study.
2. Results
2.1. Calystegine Content of Uncooked Potato Tubers
The impact of potato genetics on calystegine content was as-
sessed by review of data reported in current literature (Table 1).
The major iminosugars were found to be calystegine A3 and ca-
lystegine B2 in each potato cultivar tested when converted into
the same format (mg kg−1 DW).[22,29,30] The estimated mean con-
centrations of total calystegines ranged from 150 to 475 mg kg−1
DW in studies carried out in different countries, with an average
of content of 296 mg kg−1 DW.
2.2. Development of a Sensitive, Small-Scale LC-MS/MS Method
for Quantifying Calystegines in Cooked Potato Products and
Human Urine Based on Triple Quadrupole Technology
Due to their highly polar nature, the separation and detec-
tion of calystegines within mixtures of chemical standards
was examined using hydrophilic interaction high pressure
liquid chromatography mass spectrometry (HILIC-MS). Chro-
matographic behavior of calystegines A3, B1 and B2 chemical
standards showed good separation between A3 and B1/B2 iso-
mers although in all case the peaks were broad and showed
evidence of tailing typical of HILIC-MS (Data S3A–C, Support-
ing Information). However, there were insufficient retention
time differences between isomers B1 and B2 when applying spe-
cific MRM parameters for respective characteristic transitions
Q1:176.081–Q3:112.185 and Q1:176.081–Q3:97.137 (Table 2,
Data S3A–C, Supporting Information). Since calystegine B2
is the most abundant of all B isomers, it was decided to add
calystegine B2 alongside A3 to the calibration standards and use
the strongest transitions Q1:176.081–Q3:140.191 as a common
quantifier for potentially all calystegines B isomers (Data S3D,E,
Supporting Information). Calibration curves for calystegine
standards showed very good linearity in the concentration range
from 0.0065 to 100 µg mL−1 (Data S4, Supporting Information).
The limit-of-quantification (LOQ) and limit-of-detection (LOD)
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Table 1. Calystegine content of raw tubers of different potato cultivars.
Study and
analytical
method
Cultivar Total calystegines
content in mature
tubers [mg kg−1
DW
a)
]
Average
calystegines
content in
mature tubers
[mg kg−1 DW]
Kvasnicka et al.
(2008)[30]
Ditta 498
Granola 399
GC-MS Karin 537 475
Samanta 482
Magda 563
British Columbia
Blue
374
Griffiths et al.
(2008)[29]
Alisa 212
Brodick 222
GC-MS Cara 277 236
Maris Piper 136
Pentland Dell 333
Friedmann et al.
(2003)[22]
Atlantic 106
Dark Red Norland 34
GC-MS Ranger Russet 270
Red Lasoda 45
Russet Burbank 326 150
Russet Norkota 88
Shepody 228
Snowden 102
Peterson et al.
(2013)[20]
Juliette 581
LC-MS Maris Bard 158
Princess 104
King Edward 248
Bintje 635
Marine 401
Asterix 374 323
a)
Folva 113
Sava 275
Terra Gold 576
Melody 221
Fontane 356
Desiree 162
Average calystegine content of mature tubers = 296 mg kg−1 DW
a)
Assumes a conversion factor of 4.5 FW to DW in whole potato tubers. DW = dry
weight.
for calystegines A3 (0.0066 µg mL
−1 and 0.0020 µg mL−1, respec-
tively) and B2 (0.0219 µg mL
−1 and 0.0066 µg mL−1, respectively)
were determined (Table 2).
Although there is substantial data on the calystegine content of
raw potato tubers there is very little information on the impact of
food preparation on calystegine levels. Samples of cooked potato
products identical to those prepared by participants in the MAIN
study[31] were assessed for calystegine A3 and B isomer content
by the above MRM methodology (Figure 1). The levels of both
calystegine A3 and B isomers in cooked intact tubers with skins
on were at the higher end of the concentration range measured
in fresh potato tubers, indicating minimal losses resulting from
cooking. Processed potato products generally had a lower calyste-
gine content, related to their lack of skin tissue and percentage
tuber content.
The applicability of calystegine quantification was then tested
using selected urine samples from previously reported stud-
ies with different levels of potato consumption.[32,31] Chro-
matographic behavior of calystegines A3 and the mixture of
B isomers in representative urine samples the day after con-
sumption of varying portion size of potato are shown in
Figure 2.
2.3. The Concentrations of Calystegines A3 and B Isomers in
Urine Are Related to Potato Exposure Level in an Acute Food
Intervention
We have recently described a dietary exposure biomarker discov-
ery and validation strategy based on a food intervention study
involving free-living individuals preparing meals and collecting
urine samples at home.[31] The study design took into account
major sources of likely variance, including the impact of differ-
ent food formulations and cooking methods and using meal pat-
terns that mimic those encountered in a typical UK diet.[32] Anal-
ysis of the intervention menus[32] identified days on which the
study cohort were exposed to meals containing potato products
(Data S2, Supporting Information). In preliminary experiments
a mastermix of FMV urine samples representing high exposure
to potato products was analyzed by Triple Quadruple LC-MS/MS
to determine which of the calystegines could be detected without
inclusion of a urine fractionation or concentration step. Only ca-
lystegine A3 and a peak representing a mixture of calystegine B
isomers (predominantly calystegine B2) were detected in diluted
urine samples and thus further analysis was limited to these two
target compounds using purified A3 and B2 as calibration stan-
dards. Calystegine A3 was detected at levels ranging from 0.020
µg mL−1 to 2.75 µg mL−1 whilst the range of calystegine B iso-
mers was slightly lower with a maximal concentration of 1.03 µg
mL−1 (Figure 3 and data shown in Data S5, Supporting Informa-
tion). Urine concentrations correlated with potato exposure levels
for both biomarkers, particularly calystegine A3 (Figure 3; Spear-
man coefficient 0.64, p-value <0.001). Study participants were
exposed to several types of potato products and cooking meth-
ods (microwave chips, boiled new potatoes, baked jacket potato,
potato waffles, and oven chips). The average concentration of to-
tal calystegines in FMV urines was close to 0.004 µg mL−1 per
gram of potato consumption for all potato-based food products
(Table 3).
Low levels of calystegines have been reported in other solana-
ceous foods including tomato,[33] as well as aubergine and
pepper[28] which might limit their use as a specific biomarker
of potato exposure. Both tomato and pepper products were also
consumed as components of the six menu plans of the MAIN
study including a chicken tikka curry containing tomato puree,
baked beans in a tomato sauce, fresh tomatoes, and beef Bolog-
nese containing tinned tomatoes, and raw red and yellow pepper
(Data S2, Supporting Information). There were no significant
correlations between exposure levels of tomato or pepper and the
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Table 2. TSQ-Ultra (QQQ) quantification parameters for calystegine in urine samples.
Food exposure
class
Compound tR Ionization mode Adduct Parent (Q1)
[m/z]
Tube lens voltage [V]) Quantification product (Q3) [m/z]
Potato Calystegine A3 10.27 Pos [M+H]1+ 160.1 76 142.14
Potato Calystegine B
isomers
10.69 Pos [M+H]1+ 176.081 76 140.084
Food exposure
class
Compound SRM-Quan SRM-Qual (1) SRM-Qual (2) CE-Quan CE-Qual (1) CE-Qual (2) LOD [µg mL−1] LOQ [µg mL−1]
Potato Calystegine A3 142.14 125.12 79.31 11 15 23 0.00197 0.00656
Potato Calystegine B
isomers
140.084 112.185 158.047 14 16 12 0.00656 0.02187
tR, retention time; Q1, parent m/z; Q3, quantification product m/z; SRM, selected reaction monitoring; LOD, limit-of-detection; LOQ, limit-of-quantification; SRM-Quan,
quantification transition; SRM-Qual (1), qualifier transition 1; SRM-Qual (2), qualifier transition 2; CE-Quan, collision energy for quantification transition; CE-Qual (1), collision
energy for qualifier transition (1); CE-Qual (2), collision energy for qualifier transition (2).
Figure 1. Calystegine levels in cooked potato products measured by LC-MS. Numbers in brackets indicate the percentage content of raw potato tuber
in each potato product.
Table 3. Calystegine concentration in FMV urine after consumption of dif-
ferent potato products.
Potato product on
test day
Microwave
chips
Boiled new
potatoes
Oven chips Jacket
potatoes
and waffles
Amount consumed
[gm]
100 200 170 315
Average total
calystegine
concentration in
urine [µg mL−1]
per gram potato
product
consumed
0.0043 0.0043 0.0037 0.0039
concentrations in urine for either calystegine biomarker (Data
S6A, Supporting Information).
2.4. The Excretion Kinetics of Calystegines
To assess the utility of calystegines as potential biomarkers of
potato product exposure an acute intervention study was un-
dertaken using microwaved jacket potatoes as a representative
food (Figure 4). FMV urine samples from participants that had
avoided consuming potato-containing food products for 48 h
contained very low levels of both calystegines. Analysis of post-
prandial urines revealed a steady increase in the concentration
of both calystegines with time during the intervention day with
levels still elevated in FMV the next day. Calystegine levels were
higher in FMV urine samples on the intervention day from par-
ticipants who had only avoided potato-containing foods for 24 h.
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Figure 2. Multiple reactionmonitoring (MRM) chromatograms of calystegines A3 and B isomers in urine samples and controls. The top half of the figure
show reference quantifier and qualifier peaks for both calystegines in an example urine sample collected after consumption of a large portion of potato.
All of the transition chromatograms are scaled to relative intensity (calystegine A3, product masses m/z 79.31, 125.12, and 142.14 and calystegine B
isomers, product masses m/z 97.137, 140.191, 158.026). The lower half of the figure shows quantifier peaks in first morning void (FMV) urines after
consuming large, medium, and small portions of potato in an intervention study. A blank quality control (external QC) urine sample is included. The
reference transition peaks are aligned to quantifier chromatograms in the lower half of the figure and the vertical black dotted lines indicate the retention
time windows used to calculate peak areas.
2.5. Calystegines Are Potential Biomarkers of Potato Product
Exposure in a National Survey of Nutritional Consumption and
Physical Activity
Study participants (n = 95) in the IAN-AF study[34] were assigned
into four potato consumption categories (see Data S7, Support-
ing Information: none, n = 26; small, n = 32; medium, n = 18;
and large, n= 19) using the FSA “food portion sizes” guide) based
on 24 h dietary data. Calystegine A3 was present at approximately
twice the concentration of Calystegine B isomers in all samples
(Data S7, Supporting Information). The concentration of calyste-
gine A3 measured in FMV urine samples correlated with expo-
sure level of potato products (Spearman = 0.46; p-value 0.003:
Figure 5). The same participants were also assigned to expo-
sure groups in relation to tomato, pepper and aubergine products
(none, small, large) and urine samples screened for the presence
of calystegines (Data S6B, Supporting Information). Unlike for
potato exposure, there was no significant relationship between
the levels of tomato, pepper, and aubergine consumption and the
levels of calystegines in the urine.
3. Discussion
3.1. Impact of Genotype on Calystegine Content of Potato Tubers
For calystegines to have value as BFIs for potato it is impor-
tant to understand the likely impact of the source of potato
on calystegine content. The methods of reporting the quantity
of calystegines in potato tubers differs considerably between
investigations. For example, from a sampling perspective, some
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Figure 3. Calystegine concentrations in first morning void (FMV) urine following differential acute exposure to dietary potato products. A) Calystegine
A3; B) calystegine B isomers.
Figure 4. Excretion kinetics of calystegines after consumption of a jacket potato. Box plots show calystegine levels in urine samples taken before and
at specific time points after the intervention. Participants are grouped by the length of the wash-out period (24 vs 48 h). PRE (FMV), first morning void
urine on the day of intervention; POST (FMV), first morning void urine on the day after intervention.
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Figure 5. Calystegine A3 concentration in first morning void (FMV) urine
following differential exposure to dietary potato products in an epidemio-
logical study.
reports provide quantities for all individual calystegine isomers
(e.g., ref. [28]) in fresh uncooked tubers from a wide variety of
international sources, but provide no information with regard to
genotype. Other researchers[20] havemeasured the concentration
of just the most abundant potato calystegines (A3 and B2 and
B4) in fresh uncooked tubers and provide data on inter-cultivar
variability. The concentrations of the main potato calystegines
(A3 and B2) in freeze-dried uncooked tuber tissue from specific
cultivars has also been reported.[22,29,30] When data are expressed
on the same basis, the estimated mean concentrations of total
calystegines range from 150 to 475 mg kg−1 DW in studies
carried out in different countries (Table 1). As there is no overlap
in the potato genotypes selected for inclusion in each of these
studies the origin of this diversity is difficult to evaluate but
may reflect differences in measurement methods, or effects of
climate or agronomic practices or simply to the differences in
cultivar preferences in individual countries. Previous reports
have suggested that tuber peel contained higher concentra-
tions of calystegine compared to medulla and cortical tissues;
which may be related to the retention of “sprout” tissues in
these samples.[21,22,29,30] Although the present data revealed
that neither food processing or cooking methods significantly
altered calystegine levels in potato-containing food products,
it was noticable that calystegine concentrations were higher
in foods which retained tuber skins (Figure 1). Preliminary
analysis of early-harvested “salad” potato varieties (Gemson
and Belina) which are normally consumed without peeling
contained significantly higher concentrations of calystegines
(data not shown).
Consistent with the present data, the majority of studies
showed that the most abundant calystegine in potato tubers,
across all cultivars, is B2 followed by A3, with ratios of B2/A3 re-
ported to range from 1.7 to 6.4 in the United States[22] to 0.9–2.3
in the United Kingdom.[29] In contrast, in some studies calyste-
gine A3 appeared more abundant than B2 in potatoes.
[20,28] Al-
though these latter studies both used LC-MS analysis,[20,28] rather
than more widely used GC-MS technology, these differences are
more likely to be related to themethodology used to extract potato
tissues (Data S8, Supporting Information). From a physicochem-
ical perspective, A3 contains only three hydroxyl groups as com-
pared to four hydroxyl groups in B2 so that the polarity of the
extraction medium is likely to affect the relative efficiency of ex-
traction of the different isomers. Although this requires more
detailed investigation, it would appear that the ratio of B2/A3 re-
covered after extraction increases from acetonitrile, to methanol
and to water-based extraction, resulting in a trend for calyste-
gine A3 content to decrease and calystegine B2 to increase (Data
S8, Supporting Information). Against this background of differ-
ent measurement methodology, it remains a possibility that the
ratio of specific calystegines may differ systematically between
genotypes. Although calystegine A3 on its own performed well
as a biomarker of potato intake in the United Kingdom and Por-
tuguese studies, we suggest it will be prudent to explore also
the performance of total calystegines content to validate the fu-
ture utility of calystegines as potato tuber exposure biomarkers
in other populations.
3.2. Measurement of Calystegines in Urine Samples
Highly polar compounds such as calystegines are not well sep-
arated by conventional reverse phase chromatography, but hy-
drophilic LC-MS (HILIC) methods have proved successful in do-
ing so (reviewed by Romera-Torres et al.[23]). Good chromato-
graphic separation of calystegines A, B, and C isomers from an
extract of potato tubers was demonstrated utilizing a Luna NH2
HILIC column but all four calystegine B isomers coeluted in
a single peak.[33] We have reported recently the simultaneous
measurement ofmultiple dietary exposure biomarkers in human
urine samples using a combination of reverse phase and HILIC
chromatography.[32,31,35] Using a similar p-HILIC column (ZIC)
to measure calystegines in diluted urine samples, we demon-
strated that comparable characteristics were evident in terms of
elution order and separability. Importantly, routine quantifica-
tion was achieved without interference with the measurement of
other targeted dietary exposure biomarkers. Since calystegines A3
and B2 are themain isomers found in potatoes, a lower chromato-
graphic resolution resulting in only two respective peaks (A3 and
B isomer calystegines) for routine biomarker quantification on
ZIC p-HILIC should be adequate.
3.3. Performance of Calystegines as Specific Urine Biomarkers of
Potato Tuber Dietary Exposure
Calystegines A3 and B isomers on regression analysis showed
a linear relationship between LC-MS signal and concentration
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levels with LOQs of, respectively, 0.0066 and 0.021 µg mL−1
when measured in standard solutions. In a controlled interven-
tion study, the lowest calystegine A3 concentrations observed in
urine collected the day after potato consumption were all at least
×10 fold greater than the LOQ. In addition, although generally
present at lower concentrations than for A3, the concentrations
of B isomers were all in the quantifiable range (Data S5, Support-
ing Information and Figure 3). Examination of excretion kinetics
demonstrated a steady rise during the day of consumption and
significant carry over of calystegine from one day to the next (Fig-
ure 4), suggesting that both post-prandial and FMV urine sam-
ples were suitable for biomarker measurement. Additionally, the
study design[31] allowed a direct comparison of calystegine con-
centrations in FMV urine after consumption of three different
potato products all consumed at the same meal time on differ-
ent days (Data S5, Supporting Information and Table 3) in ei-
ther medium (microwave chips) or large (oven chips or boiled
potatoes) portion sizes. When expressed as the amount of total
calystegines per milliliter of FMV urine per gram of potato prod-
uct consumed the previous day, the values for all three different
potato formulations was on average 0.004 µg mL−1. It should be
noted that potato consumption was not always excluded in the
MAIN study on the day prior to the potato product intervention
(Data S5, Supporting Information). However, on day 1 during
the dietary intervention study (Menu 5, Data S2, Supporting In-
formation), participants consumed potato products twice during
the day (potato waffles at breakfast and jacket potatoes at dinner),
but yet again the average level of total calystegines in the next
day FMV urine per gram of potato product was 0.004 µg mL−1
(Table 3).
We suggest that these data highlight the value of using urine
samples from the MAIN study[31] (which was designed to mimic
a typical UK diet) in combination with the quantitative measure-
ment simultaneously of a panel of biomarkers to validate the real-
world performance of candidate BFIs.[12,13]
There is evidence that peel samples from uncooked mature
potatoes may contain higher concentrations of calystegines than
in the cortex and medulla regions of the tuber.[29,30] The present
data support this suggestion. However, in the present study, we
did not find that consumption of cooked potato products con-
taining peel (such as the new potatoes and jacket potatoes) re-
sulted in significantly higher calystegine levels in FMV urine (Ta-
ble 3). These observations indicate that differences in prepara-
tion/cookingmethod or assay sensitivity should have little impact
on biomarker performance. Indeed, with correlation coefficients
close to, or greater than 0.5 (Figure 3), the dose response between
quantity of potato consumed and calystegine concentrations in
FMV urine are good. The Portuguese epidemiological study pro
vided an opportunity to examine dose responsiveness in relation
to self-reported estimates (24 h, multiple pass dietary recall) of
potato intake at an even a wider range of consumption levels (Fig-
ure 5) and again calystegine A3 performed well.
A noticeable trend in the intervention study was the number
of outliers outside of the top quartile in the “large” potato
portion size intervention group (Figure 2). In addition, the
mean calystegine concentration in FMV urine of participants
consuming a “large” portion of potato products was higher in the
intervention group (≈0.4 µg mL−1) than in the epidemiological
survey (≈0.25 µg mL−1). These differences could reflect the
fact that prescribed amounts of potato were consumed in the
intervention study whereas, in the observational study, partic-
ipants over-estimated their intake of potato products. Further
investigation (Supplemental data 3) revealed that the majority of
participants classified as “large” consumers of potato products in
the intervention study also reported consuming potato products
on the day before the intervention. These data again confirm
that ingested calystegines (A3 in particular) might not be fully
excreted until at least 24–36 h after consumption. Such potential
sequestration of calystegines within the tissues leading to slower
elimination from the body would be a useful property for a
biomarker of habitual exposure in studies limited to collection
of FMV spot urine samples. Further support for this suggestion
arises from the fact that baseline concentrations of calystegine in
participants classified as “none” fell into a range that overlapped
with that found in participants classified as “medium” level
consumers. Again dietary records showed that many of these
individuals had eaten potato products the previous day. Since
food products and complex meals containing potatoes are a
very common part of the UK diet, most individuals will have
multiple exposures to potato during a typical week and this fact
will need to be taken into account when considering the use of
calystegines as a BFI in relation to criteria suggested recently.[13]
3.4. Specificity of Calystegines as Potato Tuber Biomarkers
Several studies have reported the presence of calystegines
in other solanaceous foods in addition to potato including,
aubergine, bell peppers, and tomato.[26,28,33] There is also recent
reports of calystegines in the Brassicacae,[36] but not in any food
species. Although calystegines found in urinemay also reflect ex-
posure to other types of food products, there are several lines of
evidence that suggest they are relatively specific to potato prod-
uct intake in the present study. In terms of overall contribution, it
has been reported themean content of calystegines in potatoes to
be at least 8× higher than that reported for aubergine and in the
limited number of bell peppers analyzed, only trace amounts of
calystegines were detected.[28] Similarly, calystegines have been
detected in fresh tomato and tomato products, but levels were
very low.[33] In the present study, we did not find a positive cor-
relation between exposure to tomato, bell pepper, or aubergines
and the calystegine content of urine. In relation to habitual diet,
the relative contribution of different foods to the calystegine con-
tent of urine will also be related to the frequency of exposure to
the different foods. Data from theUKNational Diet andNutrition
Survey (NDNS) Years 1–3[37] revealed that potato was consumed
by 2847 of the 3073 volunteers (93%), tomato (including puree)
was consumed by 99% of the volunteers, bell peppers were con-
sumed by 28% of the volunteers and aubergine only 1%. For the
UK population, the majority of any calystegine signal in urine
will likely be derived from potato exposure.
4. Concluding Remarks
A scheme of factors to be considered for the critical assessment
of BFI has been outlined recently.[13] The present data suggest
that calystegines, and particularly calystegine A3, score highly
Mol. Nutr. Food Res. 2020, 2000515 © 2020 The Authors. Published by Wiley-VCH GmbH2000515 (8 of 11)
www.advancedsciencenews.com www.mnf-journal.com
Table 4. Validation characteristics of calystegines as biomarker of potato
intake using the scheme devised for biomarkers of food intake (BFI’s) crit-
ical assessment.[13]
Plausibility Calystegines occur at high levels in potato tubers and
although not absolutely specific are much higher in
potato than other foods, such as aubergine, which
are eaten much less frequently.
Dose-response We show a good dose-response relationship in a
controlled intervention study at different intake
levels of foods in the context of normal (complex)
meals and eating patterns.
Time-response Excretion kinetics demonstrate that urine samples
taken either late on the day of consumption or as a
first morning void will be suitable for calystegine
quantification. Calystegine levels are almost an
order of magnitude above the quantification limit
in first morning void urines in both interventional
and epidemiological studies. There appears to be
no metabolism of calystegines (searched for
glucuronide and sulfate biotransformation
products in LC-MS data).
Robustness We have recently described a dietary intervention
study designed specifically to mimic the eating
habits of the UK population[32,31]; participants were
provided with food products and four day menus to
allow them to prepare and consume meals in their
own homes in the context of a normal UK eating
pattern (breakfast, lunch, dinner). Calystegine
levels in urine reported the intake of potato
products when presented in different formulations
and using different cooking methods that are
commonly encountered in the United Kingdom.
The levels of calystegines in potentially
confounding foods (such as aubergine) are much
lower and they are very infrequently consumed in
comparison.
Reliability Calystegine biomarkers compare well with both menu
composition and eating compliance records in an
intervention study and align well with 24 h recall
dietary data in an epidemiological study.
Stability Calystegines seem largely unaffected by a range of
food processing and cooking methods.
Calystegines, like the majority of imino-sugars
appear very stable in urine samples after storage
times of 5 years or more.
Analytical
performance and
reproducibility
Calystegine measurement by HILIC LC-MS has been
shown to be feasible as part of a complex panel of
food intake biomarkers in present study. Long term
analytical performance and reproducibility is
currently being assessed in several cohort studies.
on many validation characteristics (Table 4) and should be con-
sidered as strong candidates for biomarkers of potato product
intake.
4. Experimental Section
Ethical Approval: The MAIN Study was approved by the East Mid-
lands - Nottingham 1National Research Ethics Committee (14/EM/0040).
For the potato biomarker kinetics study, a favorable ethical opinion was
obtained following review by the Aberystwyth University Research Ethics
Panel. For the epidemiological study, ethical approval was obtained from
the National Commission for Data Protection, the Ethical Committee of
the Institute of Public Health of the University of Porto and from the Eth-
ical Commissions of each one of the Regional Administrations of Health.
All participants gave written informed consent, and the study was carried
out in accordance with the Declaration of Helsinki.
Food Intervention Study Design and Urine Sampling: The MAIN
(Metabolomics at Aberystwyth, Imperial and Newcastle) Study at Newcas-
tle included two controlled food intervention studies in free-living popu-
lations who consumed the test foods as part of two 3-day menu plans,
equating to six different menus (experimental period 1, n = 15 where
53% female, all non-smokers, age range = 22 to 63; experimental pe-
riod 2, n = 36 where 58% female, all non-smokers, age range = 19 to 77
years).[32,31] Multiple potato products were consumed over the six differ-
ent menus[31] including, microwaved chips (100 g), new potatoes boiled
with skins (200 g), potato waffles (116 g), baked jacket potato (200 g), and
oven chips (170 g) (Data S2, Supporting Information). The portion sizes
of the selected potato products were defined as small, medium, or large
with reference to the Food Standards Agency (FSA) “food portion sizes”
guide. A “large” portion was defined as >1.5 times the FSA medium por-
tion size and a “small” portion size as<0.5 times the FSAmedium portion
size.[38]
Urine sampling methods were implemented based on the previous
studies[39,40] and participants were asked to collect a series of urine sam-
ples including the first morning void (FMV) the day after each menu plan.
Potato Consumption Biomarker Excretion Kinetics: Participants (n = 7,
29% female, all non-smokers, age range = 25 to 66) were recruited and
asked to continue consuming their habitual diet, but to omit potato con-
taining products for 24–48 h prior to the study day. On the intervention
day after this washout period, they were asked to collect a first morning
void (FMV) urine at home and store at 4 °C. Participants consumed a
packed lunch consisting of a jacket potato (200 g), baked beans, mixed
leaf salad, banana, and diet lemonade. They then collected post-prandial
urine samples every 2 h until bed-time and a FMV urine sample the next
day. Participants were allowed to consume ameal lacking potatoes of their
own choice on the evening of the intervention day if desired.
Urine Sample Preparation: Urine samples were prepared and adjusted
as previously reported.[32,31] In brief, all urine samples were normalized by
refractive index prior to analysis to account for differences in fluid intake
by participants and to ensure all that all MS measurements were made
within a similar dynamic range within the linear range of the instrument.
Samples were defrosted overnight in a 4 °C fridge, centrifuged (600 × g
for 5 min at 4 °C), placed on ice and aliquots of thawed urine (1000 µL)
was transferred into labeled 2 mL Eppendorf tubes. The remaining sam-
ples were returned to a −20 °C freezer. An OPTI Hand Held Refractometer
(Bellingham Stanley Brix 54 Model) was used to record the specific gravity
(SG). Based on these figures, aliquots of the required amounts of urine
from centrifuged 2 mL Eppendorf tubes and ultra-pure (18.2Ω) H2O were
transferred into new tubes for extraction; this ensured that all samples had
the same refractive index.
Epidemiological Study and Urine Sampling: The study participants (n
= 95) were volunteers who participated in the Portuguese National Food,
Nutrition and Physical Activity Survey (IAN-AF), whose aims and meth-
ods were described previously.[34] A 24 h dietary record was collected by
trained nutritionists using the “eAT24” Software which facilitates the as-
sessment of dietary data using an automated multiple-pass method (five
steps).[41] All foods, including beverages and dietary supplements, con-
sumed were recorded per eating occasion and quantified and described
as eaten. A recipe module was also created, in which the recipes were
disaggregated into raw ingredients allowing the description and quan-
tification of each item including potato). A FMV urine sample was col-
lected in a 500 mL container and kept refrigerated (4 ºC). Samples were
aliquoted: 1 × 45 mL (in 50 mL Falcon pre-labeled tube) + 10 × 1.5 mL
(in 2 mL pre-labeled microtubes). These aliquots were refrigerated im-
mediately before being moved to −80 ºC storage, within 24 h, until
analysis.
Mol. Nutr. Food Res. 2020, 2000515 © 2020 The Authors. Published by Wiley-VCH GmbH2000515 (9 of 11)
www.advancedsciencenews.com www.mnf-journal.com
Chemicals and Reagents for LC-MS/MS: Methanol (primer trace anal-
ysis grade, Fisher Scientific, UK) was used for urine extraction and stan-
dards preparation. Acetonitrile (Optima LC/MS grade, Fisher Scientific,
UK), methanol (HPLC grade, Fisher Scientific, UK), and ammonium ac-
etate (Optima LC-MS grade, Fisher Scientific, Belgium) were used for
preparing the LCmobile phase. Water was ultra-pure water (18.2Ω) drawn
from an Elga Purelab flex water purifier system (Taiwan). Chloroform (for
HPLC stabilized with Amylene, Fisher Scientific, UK) was used for potato
product extraction. Calystegines A3, B1, and B2 standards were provided
by PhytoQuest (Aberystwyth, UK) at 95% GC-MS purity.
Potato Product Cooking and Sample Preparation for LC-MS/MS: The
potato products for calystegine analysis that were consumed in the inter-
vention study (Section 2.2) were cooked in a domestic kitchen as described
previously.[31] Briefly, the microwave chips were microwaved at full power
from frozen for 3 min. New potatoes were cooked by boiling in tap water
for 15 min until soft using the cooker hob, leaving skins on. Potato waffles
were oven baked (220 °C) from frozen until crisp and golden. The jacket
potatoes were microwaved at full power from frozen for 5 min. The oven
chips were oven cooked (220 °C) from frozen until crisp and golden. Af-
ter allowing to cool samples of potato products were stored at −20 °C in
50 mL falcon tubes; for both jacket potatoes and boiled new potatoes the
potato peel comprised at least 30% of the samples. The % dry weight of
each potato product was determined after freeze drying. For each potato
product ≈100–200 mg of frozen tissue were placed into 2 mL Eppendorf
tubes (×3 replicates) containing a 4 mm steel ball bearing, then immedi-
ately flash frozen. The final weight of each sample was recorded. Batches of
samples were processed in a Mixer Mill MM 301 (Retsch GmbH) for 30 s
at 30Hz, then 1mL of extraction solvent (2:5:2 chloroform:methanol:ultra-
pure water) added to each tube. Samples were vortexed for 10 s and then
then agitated at 1400 rpm, at 4 °C, for 20 min to extract metabolites. A
further 150 µL of methanol was added to each tube (to avoid phase sepa-
ration) which was then vortexed and centrifuged at 13 000 rpm, for 6 min
at 4 °C. 50 µL of the supernatant was then diluted with 450 µL of 70:30
ultra-pure water:methanol containing 0.1% formic acid, and 5.55 µg mL−1
of 4-chloro-dl-phenylalanine as an internal standard. Themicro-extraction
method was validated by determining the recovery of calystegines after
successive extractions of cooked potato products and subsequent quantifi-
cation of calystegines. 90% of total extractable calystegines were obtained
after the first extraction; a further two extractions led to an increase in 9%
of total calystegine content. All calystegine measurements were made on
the first extract and subsequently data were corrected for recovery.
Development of Methodology for Quantification of Calystegine Content in
Urine and Cooked Potato Products: Urine samples were prepared and an-
alyzed as reported previously.[31] Briefly, specific gravity adjusted urine
samples were diluted 1 in 10 with water:methanol (70:30, v:v) contain-
ing 0.1% formic acid and 5.55 µg mL−1 of 4-chloro-dl-phenylalanine as
an internal standard. Extracts of cooked potato products were prepared
as outlined in 2.9. Quantification of calystegines was performed on a TSQ
QuantumUltra triple quadrupole (QQQ)mass spectrometer (Thermo Sci-
entific), equipped with a heated electro-spray ionization (HESI) source
and coupled to an Accela UHPLC system (Thermo Scientific). Hydrophilic
interaction liquid chromatography (HILIC) chromatographic separation
was achieved on a ZIC-pHILIC column (polymeric 5 µm, 150 × 4.6 mm,
Merck). The mobile phase consisted of A) 10 mm ammonium acetate
in water:acetonitrile (95:5) and B) 10 mm ammonium acetate in wa-
ter:acetonitrile (5:95). A linear gradient program was used from 95% B
to 20% B in 15 min at a flow rate of 400 µL min−1. The solvent flow was
increased at 15.01 min to 500 µL min−1 and held constant for 5 min. The
column was then equilibrated at 95% B for 5 min. Column oven and au-
tosampler tray were maintained at 60 and 14 °C, respectively. To ensure
consistent sample delivery, 20 µL were injected using a 20 µL loop and
partial loop injection mode. After each injection, the syringe and injector
were cleaned using a 10%HPLC grade MeOH solution in ultra-pure water
(1 mL flush volume) to avoid sample carryover. Spectra were collected at a
scan speed of 0.010 s. A scan width of 0.010m/z, and peak width (Q1, Q3)
of 0.7 FWHM were used. Mass spectra were acquired in multiple reaction
monitoring (MRM)mode, in positive and negative ionizationmode simul-
taneously. MRM transition as well as values for shimmer offset, collision
energy, and tube lens were optimized automatically using Quantum Tune
Master (V1.5SP1, Thermo Scientific).
Absolute concentrations were calculated using a nine-point calibration
curve (0.006561–100 µg mL−1) for each calystegine. Xcalibur (V3.0.63,
Thermo Fisher Scientific Inc.) was used for peak integration, calibration,
signal-to-noise estimation, and quantification. Raw files (ThermoFisher)
were converted to mzML[42] using msconvert in the ProteoWizard tool
kit.[43] Briefly, selected reaction monitoring (SRM) chromatograms were
extracted using the R librarymzR and peak areas were calculated by extract-
ing pre-defined retention time windows (based on calibration standards)
around the peak apex. For each calibration standard, a quadratic equation
was used to model the relationship between peak area and concentration.
A squared fit of log10-transformed peak area values accommodated best
the wide concentration range for biomarkers in high and low consumers,
without compromising accuracy and normal distribution requirements for
regression analysis. Reproducibility of measurement was determined us-
ing the relative standard deviation (RSD) of a multicomponent calibration
standard containing calystegines and an external urine QC sample using
a “master mix” of pooled samples as previously reported.[32,31] Each daily
batch of samples subjected to MRM analysis contained 15–20% calibra-
tion and QC samples.
The limit of detection (LOD) and limit of quantification (LOQ) of ca-
lystegines A3 and B2 within chemical standard mixes were calculated as
the lowest concentration of each biomarker giving a signal-to-noise ratio
of 3:1 and 10:1, respectively.
Correlations between portion size and biomarker concentration in urine
were estimated using Spearman’s rank correlation. Students t-test was ap-
plied to the highest and lowest portions and biomarker concentration. In
all instances, values were first log10 transformed.
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